About Sakura Italia
Sakura Italia is a Healthcare company based in Lonato Del Garda (Italy) founded in 2004, and was acquired by Cinfa in September 2017. RD focused on manufacturing of range of drugs for mother and child health. Sakura Italia offers products and services including Gynecological Line, Immune System Line, Respiratory Line, Gastro-Intestinal Line, and Skin Line. Its focus areas include Diversified Pharmaceuticals. Its legal entity is Sakura Italia srl.
Company details
Sakura Italia was founded in 2004 as a pharmaceutical entity in Italy. Research and development activities are directed toward the production of various drugs targeting maternal and pediatric health needs. Manufacturing processes are integrated to support these specialized products, with operations primarily based in the Italian market as indicated by the domain. The focus remains on essential healthcare solutions within the sector.
Products & Services of Sakura Italia
Sakura Italia offers a comprehensive portfolio of products and services, including Gynecological Line, Immune System Line, Respiratory Line, Gastro-Intestinal Line, and Skin Line.
Products for daily hygiene and vulvo-vaginal infection treatment.
Supports immune function and addresses seasonal disorders.
Aids in treating cough, sore throat, and nasal issues.
Manages reflux, constipation, and intestinal flora balance.
Treats cutaneous injuries, burns, and supports skin healing.
Addresses heavy legs, microcirculation, and capillary fragility.
Investors in Sakura Italia
Sakura Italia has secured backing from 1 investor. Prominent investors backing the company include Cinfa.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Prescription medicines, OTC products, and cosmetics are manufactured by Cinfa. | 1996 | cinfa.com | Spain |
Investor details for Sakura Italia
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Sakura Italia
2 dated milestones of Sakura Italia across 13 years, from founding to its latest funding, stage changes and deals.
- Founded Sakura Italia is founded.
- Exit Acquired by Cinfa.
Web traffic of Sakura Italia
The website of Sakura Italia (sakuraitalia.it) receives about 1.8K visits a month.
- Monthly visits1.8K
▼ 22% vs previous month
Websites whose visitors overlap most with Sakura Italia. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
vulvodiniapuntoinfo.com | vulvodiniapuntoinfo.com | 100% | – | ||
afarma.it | afarma.it | 64% | #828,419 | – | |
visivaistai.lt | visivaistai.lt | 60% | #5,924,494 | – | |
lusodidacta.pt | lusodidacta.pt | 43% | #3,152,004 | – | |
arkopharma.it | arkopharma.it | 43% | – | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 9 similar websites and full traffic analytics for Sakura Italia
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 9 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Sakura Italia
Sakura Italia was founded in 2004.
Sakura Italia is headquartered in Lonato Del Garda, Italy. It is registered at Lonato Del Garda, Lombardy, Italy.
Sakura Italia was founded in 2004 as a pharmaceutical entity in Italy. Research and development activities are directed toward the production of various drugs targeting maternal and pediatric health needs. Manufacturing processes are integrated to support these specialized products, with operations primarily based in the Italian market as indicated by the domain. The focus remains on essential healthcare solutions within the sector.
Sakura Italia offers Gynecological Line, Immune System Line, Respiratory Line, Gastro-Intestinal Line, and 2 more products and services.
Sakura Italia has 1 investor. Key investors include Cinfa.
Sakura Italia operates through Sakura Italia Srl.
Yes. Sakura Italia was acquired by Cinfa in September 2017.